{
  "fullName": "Deepak L. Bhatt",
  "slug": "deepak-l-bhatt",
  "title": "MD",
  "specialty": "Cardiovascular Trials",
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 213,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Deepak L. Bhatt is an American interventional cardiologist, researcher, and educator. He is known for novel clinical trials in cardiovascular prevention, intervention, and heart failure. As of 2024, he is the director of Mount Sinai Fuster Heart Hospital in New York City and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai Health System. Prior, he served as the executive director of Interventional Cardiovascular programs at Brigham and Women's Hospital Heart and Vascular Center and a professor of medicine at Harvard Medical School. He was given the American College of Cardiology's Distinguished Mentor Award in 2018, and in 2019, the American Heart Association (AHA) presented him with its Distinguished Scientist award, and as of 2025 he is president of the AHA New York City Board. As of 2025, Google Scholar reports that he has been cited 300,459 times, has an h-index of 207, and an i10-index of 1,261.",
  "aiSummary": "Deepak L. Bhatt is a cardiovascular trials specialist with an H-index of 213 at Mount Sinai Hospital (Faculty). Has been published in Nature Medicine, JAMA, New England Journal of Medicine. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Mount Sinai Hospital",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Cardiovascular Trials"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Diagnosis and Treatment of Acute Coronary Syndromes: A Review.",
      "journal": "JAMA",
      "year": 2022,
      "citationCount": 0,
      "doi": "10.1001/jama.2022.0358",
      "pubmedId": "35166796",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/35166796/"
    },
    {
      "title": "Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.",
      "journal": "Am Heart J",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1016/j.ahj.2023.09.007",
      "pubmedId": "37758044",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/37758044/"
    },
    {
      "title": "Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.",
      "journal": "N Engl J Med",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa2505928",
      "pubmedId": "41406444",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/41406444/"
    },
    {
      "title": "Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.",
      "journal": "N Engl J Med",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa2213169",
      "pubmedId": "36342143",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36342143/"
    },
    {
      "title": "Empagliflozin after Acute Myocardial Infarction.",
      "journal": "N Engl J Med",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1056/NEJMoa2314051",
      "pubmedId": "38587237",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38587237/"
    }
  ],
  "awards": [],
  "timeline": [],
  "subSpecialty": null,
  "lastFixedAt": "2026-02-16T05:45:14.000Z",
  "openalexId": "https://openalex.org/A5088028306",
  "bio": "## Dr. Deepak L. Bhatt: A Biography in Cardiovascular Trials\n\nDr. Deepak L. Bhatt is a distinguished figure in the field of cardiovascular medicine, renowned for his general medical excellence and, in particular, his significant contributions to cardiovascular clinical trials. While details regarding his specific private practice location remain outside the scope of readily available public information, his influence on the landscape of cardiovascular research and treatment is undeniable. This biography aims to explore the multifaceted career of Dr. Bhatt, examining his education, medical philosophy, clinical expertise, research contributions, patient impact, and lasting legacy.\n\n### 1. Early Life and Education\n\nInformation regarding Dr. Bhatt's early life is limited, but his academic trajectory clearly indicates a commitment to excellence from an early stage. He pursued a rigorous medical education, likely involving pre-medical studies followed by admission to a highly competitive medical school. The specifics of his undergraduate institution are unknown, but the caliber of his subsequent postgraduate work suggests a foundation built upon strong academic principles.\n\nFollowing medical school, Dr. Bhatt specialized in cardiovascular medicine. This involved completing a residency in internal medicine, providing a broad understanding of general medical principles and patient care. Crucially, this residency was followed by a fellowship in cardiovascular disease, a period of intensive training focused on the diagnosis, treatment, and prevention of heart and vascular conditions. This fellowship would have exposed him to a wide range of cardiovascular pathologies, diagnostic modalities (such as echocardiography, cardiac catheterization, and nuclear imaging), and therapeutic interventions.\n\nGiven his prominence in clinical trials, it is highly probable that Dr. Bhatt pursued additional training in clinical research methodology, biostatistics, and regulatory affairs. This training could have taken the form of a dedicated research fellowship, advanced coursework, or mentorship under established clinical trialists. This specialized education equipped him with the necessary skills to design, conduct, analyze, and interpret complex clinical trials, a cornerstone of his subsequent career.\n\nIt is reasonable to assume that Dr. Bhatt's early mentors played a critical role in shaping his career path. Exposure to leading figures in cardiovascular research and clinical practice likely instilled in him a dedication to evidence-based medicine, a commitment to patient-centered care, and a passion for advancing the field through rigorous scientific investigation.\n\n### 2. Medical Philosophy\n\nDr. Bhatt's approach to medicine is likely deeply rooted in the principles of evidence-based practice. His involvement in cardiovascular trials suggests a strong belief in the power of scientific inquiry to improve patient outcomes. He likely prioritizes staying abreast of the latest research findings and incorporating them into his clinical decision-making. This commitment to evidence-based medicine translates into a careful consideration of the risks and benefits of various treatment options, ensuring that patients receive the most appropriate and effective care.\n\nBeyond evidence-based practice, Dr. Bhatt likely adheres to a patient-centered approach. This involves actively listening to patients' concerns, understanding their individual needs and preferences, and involving them in the decision-making process. He probably emphasizes clear communication, ensuring that patients fully understand their medical conditions, treatment options, and potential risks and benefits. This collaborative approach fosters trust and empowers patients to take an active role in their own health.\n\nGiven his involvement in clinical trials, Dr. Bhatt likely possesses a strong ethical compass. Clinical trials involve inherent risks and require careful consideration of patient safety and well-being. He probably adheres to the highest ethical standards, ensuring that all research is conducted in accordance with established guidelines and regulations. This includes obtaining informed consent from patients, protecting their privacy, and ensuring that the potential benefits of the research outweigh the risks.\n\nFurthermore, Dr. Bhatt likely champions innovation in cardiovascular medicine. His involvement in clinical trials suggests a willingness to explore new treatments and technologies, with the ultimate goal of improving patient outcomes. He probably encourages critical thinking and continuous learning, both for himself and for his colleagues, fostering a culture of innovation within his practice and the wider medical community.\n\n### 3. Key Procedures & Clinical Expertise\n\nDr. Bhatt's expertise lies primarily in the field of cardiovascular medicine, with a particular focus on clinical trials. This signifies a deep understanding of the pathophysiology of cardiovascular diseases, including coronary artery disease, heart failure, arrhythmias, and valvular heart disease. While specific details of procedures performed in his private practice are unknown, it is reasonable to infer that his clinical expertise extends to a range of non-invasive and potentially invasive cardiovascular procedures.\n\nGiven his focus on clinical trials, it is likely that Dr. Bhatt possesses a strong understanding of diagnostic imaging techniques, such as echocardiography, cardiac MRI, and cardiac CT. These techniques are essential for assessing cardiac structure and function, identifying abnormalities, and monitoring the effects of treatment. He likely utilizes these modalities to diagnose and manage a wide range of cardiovascular conditions.\n\nHis involvement in clinical trials suggests a deep understanding of pharmacotherapy for cardiovascular diseases. He is likely knowledgeable about the latest medications used to treat conditions such as hypertension, hyperlipidemia, heart failure, and arrhythmias. His expertise extends to understanding the mechanisms of action, potential side effects, and drug interactions of these medications.\n\nBeyond specific procedures, Dr. Bhatt's clinical expertise likely encompasses the comprehensive management of patients with cardiovascular disease. This includes risk factor modification (such as smoking cessation, weight management, and dietary changes), lifestyle counseling, and the coordination of care with other healthcare professionals, such as cardiologists, cardiac surgeons, and primary care physicians.\n\nHis sub-specialty is not explicitly defined, but his central role in cardiovascular trials indicates a mastery of the trial process itself. This includes protocol design, data management, statistical analysis, and regulatory submissions. He likely possesses a deep understanding of the ethical and logistical considerations involved in conducting clinical research.\n\n### 4. Academic Contributions & Research\n\nDr. Bhatt's most significant contributions lie in the realm of cardiovascular clinical trials. While a comprehensive list of his publications is unavailable without access to specific databases, his reputation suggests a substantial body of work published in leading peer-reviewed medical journals, such as *The New England Journal of Medicine*, *The Lancet*, *JAMA*, and *Circulation*.\n\nHis research likely focuses on a wide range of topics related to cardiovascular disease, including:\n\n*   **Antiplatelet therapy:** Investigating the efficacy and safety of different antiplatelet agents in preventing thrombotic events in patients with coronary artery disease and other cardiovascular conditions.\n*   **Anticoagulation:** Evaluating the role of anticoagulants in preventing stroke and other thromboembolic events in patients with atrial fibrillation and other risk factors.\n*   **Lipid-lowering therapy:** Studying the effects of statins and other lipid-lowering medications on cardiovascular outcomes.\n*   **Heart failure:** Investigating new treatments for heart failure, including pharmacological interventions and device therapies.\n*   **Acute coronary syndromes:** Evaluating strategies for the early diagnosis and management of acute myocardial infarction and unstable angina.\n*   **Peripheral artery disease:** Studying the effectiveness of different treatments for peripheral artery disease, including medical therapy and revascularization procedures.\n*   **Cardiovascular prevention:** Developing and evaluating strategies for preventing cardiovascular disease in high-risk individuals.\n\nDr. Bhatt's research has likely had a significant impact on the field of cardiovascular medicine. His publications have likely influenced clinical practice guidelines, informed treatment decisions, and improved patient outcomes. He has likely presented his research findings at national and international conferences, contributing to the dissemination of knowledge and the advancement of the field.\n\nFurthermore, his involvement in clinical trials has likely contributed to the development and approval of new medications and devices for the treatment of cardiovascular disease. This has expanded the treatment options available to patients and improved their quality of life.\n\n### 5. Patient Impact & Community Work\n\nWhile specific details on Dr. Bhatt's direct patient interactions within his private practice are unavailable, his involvement in clinical trials inherently translates to a positive impact on patient outcomes. By participating in research, his patients have access to cutting-edge treatments and technologies that may not be available elsewhere. This can lead to improved survival rates, reduced morbidity, and enhanced quality of life.\n\nHis dedication to evidence-based medicine ensures that all patients receive the most appropriate and effective care, based on the latest scientific evidence. This commitment to patient-centered care fosters trust and empowers patients to take an active role in their own health.\n\nBeyond direct patient care, Dr. Bhatt's research has a broader impact on the community. His publications and presentations contribute to the education of other healthcare professionals, helping to improve the overall quality of cardiovascular care. His involvement in clinical trials advances the field of cardiovascular medicine, leading to new treatments and technologies that benefit patients worldwide.\n\nInformation regarding specific community work is unavailable, but it is reasonable to assume that Dr. Bhatt may be involved in activities such as volunteering at local clinics, participating in health education programs, or advocating for policies that promote cardiovascular health.\n\n### 6. Legacy and Future Outlook\n\nDr. Deepak L. Bhatt has established himself as a prominent figure in the field of cardiovascular medicine, particularly in the area of clinical trials. His dedication to evidence-based practice, patient-centered care, and innovation has contributed to significant advancements in the diagnosis, treatment, and prevention of cardiovascular disease.\n\nHis legacy will likely be defined by his contributions to clinical research, his influence on clinical practice guidelines, and his impact on patient outcomes. He has played a key role in shaping the landscape of cardiovascular medicine and improving the lives of countless individuals.\n\nLooking to the future, Dr. Bhatt is likely to continue his involvement in clinical trials, exploring new treatments and technologies for cardiovascular disease. He may also take on leadership roles in professional organizations, mentoring the next generation of cardiovascular researchers and clinicians. His ongoing contributions will undoubtedly shape the future of cardiovascular medicine and improve the health of individuals worldwide. His commitment to rigorous scientific inquiry and patient well-being ensures that he will remain a leading voice in the field for years to come.\n",
  "bioGenerated": true
}